{"id":514976,"date":"2020-11-02T23:08:01","date_gmt":"2020-11-02T23:08:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=514976"},"modified":"2020-11-02T23:08:01","modified_gmt":"2020-11-02T23:08:01","slug":"vaccine-contract-manufacturing-market-size-worth-40-billion-by-2025-grand-view-research-inc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/vaccine-contract-manufacturing-market-size-worth-40-billion-by-2025-grand-view-research-inc_514976.html","title":{"rendered":"Vaccine Contract Manufacturing Market Size Worth $4.0 Billion By 2025: Grand View Research, Inc."},"content":{"rendered":"
\"Vaccine<\/a><\/p>\n
\n
Grand View Research, Inc. – Market Research And Consulting.<\/div>\n<\/div>\n<\/div>\n
The global vaccine contract manufacturing market size was valued at USD 1.8 billion in 2016 and is projected to expand at a CAGR of 9.3% during the forecast period.<\/div>\n

The global vaccine contract manufacturing market<\/a><\/strong> size is expected to reach USD 4.0 billion<\/strong> by 2025<\/strong>, according to a new report by Grand View Research, Inc., expanding at a 9.3% CAGR<\/strong> during the forecast period. The market is anticipated to witness significant growth over the coming years thanks to rising demand for vaccine development from the private sector as well as governments in industrialized and developing countries.<\/p>\n

Vaccine contract services offer cost-saving benefits to their clients. They also help save time in the operations and management of a production and research facility. These advantages associated with Contract Manufacturing Organizations (CMOs) are expected to benefit emerging players, start-ups, and small players who lack adequate facilities and resources required for vaccine development.<\/p>\n

\"India<\/strong><\/p>\n

Request a sample Copy of the Global Vaccine Contract Manufacturing Market Research Report @ <\/strong>https:\/\/www.grandviewresearch.com\/industry-analysis\/vaccine-contract-manufacturing-market\/request\/rs1<\/strong><\/a><\/p>\n

An increase in pricing pressure, regulatory challenges, and patent expiration in recent times are expected to adversely impact the market. Contract services are considered “strategic competitive weapons” among vaccine manufacturers as they help overcome the aforementioned issues.<\/p>\n

A number of international healthcare organizations are engaged in estimating and predicting the number of goods as well as the financial need required for conducting immunization programs. Some of the factors considered for this estimation are the number of vaccines, estimated time of delivery, product type, and vial size. The participation of international healthcare organizations in vaccination programs is expected to positively influence the growth of contract manufacturers.<\/p>\n

Key suggestions from the report:<\/strong><\/p>\n